05:47 PM EST, 12/17/2025 (MT Newswires) -- Marshall Urist, Executive Vice President, Research & Investments, on December 16, 2025, sold 20,000 shares in Royalty Pharma ( RPRX ) for $766,420. Following the Form 4 filing with the SEC, Urist has control over a total of 166,418 Class A ordinary shares of the company, with 7,398 shares held directly and 159,020 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1802768/000183813925000010/xslF345X05/wk-form4_1766011394.xml